AstraZeneca two-in-one drug succeeds in lung disease test
March 18, 2015 at 03:28 AM EDT
LONDON, March 18 (Reuters) - AstraZeneca said on Wednesday its experimental lung drug PT003 for chronic lung disease had proved successful in two final-stage Phase III trials, boosting hopes for the company's respiratory pipeline.
